Navigation Links
FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
Date:1/22/2014

Bethesda, MD This FASEB Science Research Conference focuses on signaling pathway feedback loops, reprogramming and mechanisms of drug resistance due to signaling rewiring. A growing appreciation has emerged that though many of the core components of signaling pathways have been identified in the last three decades an in depth understanding of the dynamics, spatial constraints and contextual inputs needs to be elucidated.

The conference will focus on advances on the elaboration of signaling feedback loops underlying resistance in cancer as a model system. Highlights of the conference will include the structural elucidation of kinase regulation, analysis of crosstalk and complex signaling networks, scaffold proteins and kinase signal sensitization, kinases in stress response and nutrient sensing, the role of protein kinases, and their downstream targets regulating growth, adhesion, invasion, metastasis, the use of quantitative mass spectrometry and therapeutic kinase inhibitor strategies.

Travel grants and poster awards will be available for trainees. An impressive slate of world-renown speakers combined with the intimacy of a highly focused agenda with ample opportunities for discussion and interaction, are designed to enhance collaboration and foster new ideas and research directions in the field.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
2. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
3. FASEB announces BioArt image and video competition winners
4. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
5. MARC travel awards announced for the June 2013 FASEB science research conferences
6. New FASEB analysis documents impact of budget cuts on biomedical research
7. FASEB MARC Travel Awards announced for the 2013 American College of Sports Medicine Northwest Chapter Meeting
8. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
9. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
10. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
11. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: